Retraction: Grape seed proanthocyanidins inhibit the invasiveness of human HNSCC cells by targeting EGFR and reversing the epithelial-to-mesenchymal transition (PLoS One (2012) 7:1 (e31093) DOI: 10.1371/journal.pone.0031093);Grape seed proanthocyanidins inhibit the invasiveness of human HNSCC cells by targeting EGFR and reversing the epithelial-to-mesenchymal transition

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Sun, Qian ^b   Prasad, Ram ^b   Rosenthal, Eben ^b   Katiyar, Santosh K ^a,b  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; CYTOKERATIN; DESMOGLEIN 2; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FIBRONECTIN; GEFITINIB; GRAPE SEED EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE CELL ADHESION MOLECULE; PROANTHOCYANIDIN; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SLUG; UVOMORULIN; VIMENTIN; ANTINEOPLASTIC AGENT; GRAPE SEED PROANTHOCYANIDINS;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL ASSAY; CELL INVASION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS POTENTIAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; CELL ADHESION; CELL MOTION; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; METABOLISM; PATHOLOGY; PROTO ONCOGENE; TUMOR CELL LINE;

VITACEAE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-1; GRAPE SEED EXTRACT; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM INVASIVENESS; PROANTHOCYANIDINS;

EID: 84856377511     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0210346     Document Type: Erratum

References (29)

1. Arbes SJ Jr, Olshan AF, Caplan DJ, Schoenbach VJ, Slade GD, et al. (1999) Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States). Cancer Causes Control 10: 513-523.
2. Hunter KD, Parkinson EK, Harrison PR, (2005) Profiling early head and neck cancer. Nat Rev Cancer 5: 127-135.
3. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, et al. (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357: 1695-1704.
4. Leon X, Quer M, Orus C, del Prado Venegas M, (2001) Can cure be achieved in patients with head and neck carcinomas? The problem of second neoplasm. Expert Rev Anticancer Ther 1: 125-133.
5. Casiglia J, Woo SB, (2001) A comprehensive review of oral cancer. Gen Dent 49: 72-82.
6. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, et al. (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357: 1705-1715.
7. Mittal A, Elmets CA, Katiyar SK, (2003) Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis 24: 1379-1388.
8. Meeran SM, Vaid M, Punathil T, Katiyar SK, (2009) Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7, 12-dimethylbenz(a)anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Carcinogenesis 30: 520-528.
9. Nandakumar V, Singh T, Katiyar SK, (2008) Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 269: 378-387.
10. Grandis JR, Melhem MF, Barnes EL, Tweardy DJ, (1996) Quantitative immunohistochemical analysis of transforming growth factor-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 78: 1284-1292.
11. Grandis JR, Melhem MF, Gooding WE, Day R, Holst VA, et al. (1998) Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90: 824-832.
12. He Y, Zeng Q, Drenning SD, Melhem MF, Tweardy DJ, et al. (1998) Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter. J Natl Cancer Inst 90: 1080-1087.
13. Leeman-Neill RJ, Seethala RR, Singh SV, Freilino ML, Bednash JS, et al. (2011) Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma. Cancer Prev Res (Phila) 4: 230-237.
14. Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, et al. (2004) NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114: 569-581.
15. Thiery JP, (2002) Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2: 442-454.
16. Maier HJ, Wirth T, Beug H, (2010) Epithelial-mesenchymal transition in pancreatic carcinoma. Cancers 2: 2058-2083.
17. Mantena SK, Sharma SD, Katiyar SK, (2006) Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase-3 and PARP. Carcinogenesis 27: 2018-2027.
18. Vaid M, Prasad R, Sun Q, Katiyar SK, (2011) Silymarin targets β-catenin signaling in blocking migration/invasion of human melanoma cells. PLoS ONE 6 (7) doi:10.1371/journal. pone.0023000: e23000.
19. Singh T, Katiyar SK, (2011) Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition. PLoS ONE 6 (10): e25224 Doi:10.1371/journal.pone.0025224.
20. Meeran SM, Katiyar N, Singh T, Katiyar SK, (2009) Loss of endogenous interleukin-12 activates survival signals in UV-exposed mouse skin and skin tumors. Neoplasia 11: 846-855.
21. Zuo JH, Zhu W, Li MY, Li XH, Yi H, et al. (2011) Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 112: 2508-2517.
22. Akhtar S, Meeran SM, Katiyar N, Katiyar SK, (2009) Grape seed proanthocyanidins inhibit the growth of human non-small cell lung cancer xenografts by targeting IGFBP-3, tumor cell proliferation and angiogenic factors. Clinical Cancer Res 15: 821-831.
23. Singh RP, Tyagi AK, Dhanalakshmi S, Agarwal R, Agarwal C, (2004) Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3. Int J Cancer 108: 733-740.
24. Min C, Eddy SF, Sherr DH, Sonenshein GE, (2008) NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem 104: 733-744.
25. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, et al. (2007) NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26: 711-724.
26. Huber MA, Beug H, Wirth T, (2004) Epithelial-mesenchymal transition: NF-kappaB takes center stage. Cell Cycle 3: 1477-1480.
27. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C, (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81: 230S-242S.
28. Sano A, Yamakoshi J, Tokutake S, Tobe K, Kubota Y, et al. (2003) Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract. Biosci Biotechnol Biochem 67: 1140-1143.
29. Holt RR, Lazarus SA, Sullards MC, Zhu QY, Schramm DD, et al. (2002) Procyanidin dimer B2 [epicatechin-(4β-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr 76: 798-804.